Section 32 was founded on the premise that a small, high-conviction venture firm can commit deeply to a narrow set of core relationships and stand behind founders for the long term. It deliberately constrains its capital to force a choice between excellent opportunities rather than deployment into marginal ones, and it pairs its investing with an in-house talent team that supports the companies it backs.
Section 32 invests across artificial intelligence, computational biology, physical AI, infrastructure, cybersecurity, and enterprise software, and differentiates itself by staying deliberately capital constrained and concentrating on a small set of core relationships rather than deploying into marginal opportunities. Its audience is the founders of the technology companies it backs, who work directly with the firm's talent team.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.
Top Investment Stages

Basecamp Research

Snorkel AI

empirik

humans&

Culture Biosciences

Inductive Bio

Character Biosciences

Puzzle

Puzzle Financial

ROME Therapeutics

Inceptive

Endor Labs

Octave Bioscience

AltPep

Delve Bio

Function Oncology

Faro Health

Forward Networks

MedCrypt

Neocis

Stairwell

Nested Therapeutics

Autobahn Therapeutics

Spectral

Inworld AI

Conviction Partners
conviction.com

AI List Capital
ailist.io

Security Leadership Capital
slc.vc

AIC
aicapital.ai

Parkway Venture Capital
parkway.vc

Good AI Capital
goodai.capital

Sorenson Ventures

Formus Capital
formuscap.com

Sancus Ventures
sancusvc.com

Fellows Fund
fellowsfundvc.com

Gpvc
generalpurpose.vc

U&I Ventures
uandi.vc

GoldenArc Capital
goldenarccap.com

Index Ventures
indexventures.com

SuperSeed
superseed.com

R136 Ventures
r136.vc
SV Pacific Ventures
svpventures.com

Executive Enterprise Venture Fund

Squadra Ventures
squadra.vc

7BC
7bc.vc